Financing
Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets™
MarketsandMarkets™
PR-10-24-NI-67Oct 29, 2024
Biologics
Chime Biologics and MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing
Chime Biologics
PR-10-24-NI-66Oct 29, 2024
Financing
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline
AbbVie
PR-10-24-NI-65Oct 29, 2024
Clinical Trials
TREMFYA is the first and only IL-23 inhibitor to demonstrate robust results with regimen in both induction and maintenance
Johnson & Johnson
PR-10-24-NI-64Oct 28, 2024
Preclinical Data
Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene for the Treatment of Hereditary Angioedema
Poseida Therapeutics
PR-10-24-NI-63Oct 25, 2024
Clinical Data
Skyhawk Therapeutics Presents Compelling Preclinical Data at the Molecular Targets and Cancer Therapeutics Symposium
Skyhawk
PR-10-24-NI-62Oct 25, 2024
Clinical Trial
Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure
Abbott
PR-10-24-NI-61Oct 25, 2024
Clinical Development
Children's Hospital of Philadelphia Researchers Find Promising New Immunotherapy Target in Neuroblastoma and Other Cancers
Children's Hospital of Philadelphia
PR-10-24-NI-60Oct 25, 2024
Announcement
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
SK bioscience
PR-10-24-NI-59Oct 23, 2024
Financing
Samsung Biologics reports third quarter 2024 financial results
Samsung Biologics
PR-10-24-NI-58Oct 23, 2024
Clinical Development
Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery
Dotmatics
PR-10-24-NI-57Oct 22, 2024
Cell Therapy
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
Cryoport
PR-10-24-NI-56Oct 22, 2024
Clinical Research
Tc Biopharm
TC Biopharm
PR-10-24-NI-55Oct 22, 2024
CDMO
Mikart Adds Nitrogen-Purged Capability to Liquid and Suspension Suites
Mikart
PR-10-24-NI-54Oct 22, 2024
Clinical Trials
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
Inovio Pharmaceuticals, Inc.
PR-10-24-NI-53Oct 21, 2024
Biopharma
Life Sciences and Cryoport Form Partnership to Elevate Standards for Frozen Egg, Embryo, etc Offsite Storage and Biologistics
Cryoport
PR-10-24-NI-52Oct 21, 2024
Clinical Development
MOBILion Systems Unveils Novel High Resolution Mass Spectrometry Functionality for Proteomics Workflows
MOBILion Systems, Inc.
PR-10-24-NI-51Oct 21, 2024
Financing
mRNA Synthesis & Manufacturing Market to Hit USD 738.3 Million by 2029 with 3.4% CAGR | MarketsandMarkets™
MarketsandMarkets™
PR-10-24-NI-50Oct 17, 2024
Announcement
Orasis Pharmaceuticals Announces Licensing Agreement with Optus Pharmaceuticals for Commercialization of Qlosi™ 0.4% in Korea
Orasis Pharmaceuticals
PR-10-24-NI-49Oct 17, 2024
Clinical Trials
Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
Novavax
PR-10-24-NI-48Oct 17, 2024